Cytogenetic analysis of 39 prostate carcinomas and evaluation of short term tissue culture techniques

Cancer Genetics and Cytogenetics

Volumn 101, Issue 2, 1998, Pages 116-122

  König, Josée J ^a   Teubel, Wilma ^a   Kamst, Eric ^a   Romijn, Johannes C ^a   Schröder, Fritz H ^a   Hagemeijer, Anne ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR;

ARTICLE; CELL PROLIFERATION; CHROMOSOME 8P; CYTOGENETICS; DIPLOIDY; GENE DELETION; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; METAPHASE; PRIORITY JOURNAL; PROSTATE CARCINOMA; TISSUE CULTURE;

CARCINOMA; CELL DIVISION; CELLS, CULTURED; CULTURE TECHNIQUES; EVALUATION STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; KARYOTYPING; KERATINS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0032032323     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00224-0     Document Type: Article

References (30)

1. Sandberg AA Chromosomal abnormalities and related events in prostate cancer. Hum Pathol. 23:1992;368-380.
2. Micale MA, Mohamed A, Sakr W, Powell IJ, Wolman SR Cytogenetics of primary prostatic adenocarcinoma. Clonality and chromosome instability. Cancer Genet Cytogenet. 61:1992;165-173.
3. Arps S, Rodewald A, Schmalenberger B, Carl P, Bressel M, Kastendieck H Cytogenetic survey of 32 cancers of the prostate. Cancer Genet Cytogenet. 66:1993;93-99.
4. Lundgren R, Mandahl N, Heim S, Limon J, Hendrikson H, Mitelman F Cytogenetic analysis of 57 primary prostatic adenocarcinomas. Genes Chromosom Cancer. 4:1992;16-24.
5. Peehl DM, Stamey TA Growth responses of normal, benign hyperplastic, and malignant human prostatic epithelial cells in vitro to cholera toxin, pituitary extract, and hydrocortisone. Prostate. 8:1985;51-61.
6. McKeehan WL, Adams PS, Fast D Different hormonal requirements for androgen-independent growth of normal and tumor epithelial cells from rat prostate. In Vitro. 23:1987;147-152.
7. Svanholm H, Nielsen B, Starklint H Keratin patterns in prostatic hyperplasia and adenocarcinoma. APMIS suppl. 4:1988;100-108.
8. Verhagen APM, Ramaekers FCS, Aalders TW, Schaafsma HE, Debruyne FMJ, Schalken JA Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res. 52:1992;6182-6187.
9. Gerbault-Seureau M, Vielh P, Dutrillaux B Recurrent HSR in the centromeric region of chromosome 8 in breast cancer. Ann Genet. 30:1987;146-151.
10. Limon J, Lundgren R, Elfving P, Heim S, Kristofferson U, Mandahl N, Mitelman F An improved technique for short-term culturing of human prostatic adenocarcinoma tissue for cytogenetic analysis. Cancer Genet Cytogenet. 46:1990;191-199.
11. König JJ, Hagemeijer A, Smit B, Kamst E, Romijn JC, Schröder FH Cytogenetic characterization of an established xenografted prostatic carcinoma cell line (PC-82). Cancer Genet Cytogenet. 34:1988;91-99.
12. Romijn JC, Verkoelen CF, Schröder FH Application of the MTT assay to human prostate cancer cell lines in vitro. establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects Prostate. 12:1988;99-110.
13. Trent J, Crickard K, Gibas Z, Goodacre A, Pathak S, Sandberg AA, Thompson F, Whang-Peng J, Wolman S Methodologic advances in the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet. 19:1986;57-66.
14. Gallee MP, Visser-de Jong E, van der Korput JA, van der Kwast TH, ten Kate FJ, Schröder FH, Trapman J Variation of prostate-specific antigen expression in different tumor growth patterns present in prostatectomy specimens. Urol Res. 18:1990;181-187.
15. Baretton GB, Valina C, Vogt T, Schneiderbanger K, Diebold J, Lohrs U Interphase cytogenetics of prostatic carcinomas by use of nonisotopic in situ hybridization. Cancer Res. 54:1994;4472-4480.
16. Visakorpi T, Hyytinen E, Kallioniemi A, Isola J, Kallioniemi OP Sensitive detection of chromosome copy number aberrations in prostate cancer by fluorescence in situ hybridization. Am J Pathol. 145:1994;624-630.
17. Alers JC, Krijtenburg PJ, Vissers KJ, Bosman FT, van der Kwast TH, van Dekken H Interphase cytogenetics of prostatic adenocarcinoma and precursor lesions. analysis of 25 radical prostatectomies and 17 adjacent prostatic intraepithelial neoplasias Genes Chromosom Cancer. 12:1995;241-250.
18. Cher ML, MacGrogan D, Bookstein R, Brown JA, Jenkins RB, Jensen RH Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosom Cancer. 11:1994;153-162.
19. Macoska JA, Trybus TM, Sakr WA, Wolf MC, Benson MC, Powell IJ, Pontes JE Fluorescence in situ hybridization analysis of 8p allelic loss and chromosome 8 instability in human prostate cancer. Cancer Res. 54:1994;3824-3830.
20. König JJ, Teubel W, Romijn JC, Schröder FH, Hagemeijer A Gain and loss of chromosomes 1, 7, 8, 10, 18, and Y in 46 prostate cancers. Hum Pathol. 27:1996;720-727.
21. Brothman AR, Peehl DM, Patel AM, McNeal JE Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res. 50:1990;3795-3803.
22. Bandyk MG, Zhao L, Troncoso P, Pisters LL, Palmer JL, Eschenbach AC von, Chung LWK, Liang JC Trisomy 7. a potential cytogenetic marker for human prostate cancer progression Genes Chromosom Cancer. 9:1994;19-27.
23. König JJ, van Dongen JJW, Schröder FH Preferential loss of abnormal prostate carcinoma cells by collagenase treatment. Cytometry. 14:1993;803-810.
24. König JJ, Teubel W, van Dongen JJW, Hagemeijer A, Romijn JC, Schröder FH Tissue culture loss of aneuploid cells from carcinomas of the prostate. Genes Chromosom Cancer. 8:1993;22-27.
25. Nativ O, Myers RP, Farrow GM, Therneau TM, Zincke H, Lieber MM Nuclear deoxyribonucleic acid ploidy and serum prostate specific antigen in operable prostatic adenocarcinoma. J Urol. 144:1990;303-306.
26. Miller J, Horsfall DJ, Marshall VR, Rao DM, Leong ASY The prognostic value of deoxyribonucleic acid flow cytometric analysis in stage D2 prostatic carcinoma. J Urol. 145:1991;1192-1196.
27. König JJ, Teubel W, van Dongen JJW, Romijn JC, Hagemeijer A, Schröder FH Loss and gain of chromosomes 1, 18 and Y in prostate cancer. Prostate. 25:1994;281-291.
28. Brown JA, Alcaraz A, Takahashi S, Persons DL, Lieber MM, Jenkins RB Chromosomal aneusomies detected by fluorescence in situ hybridization analysis in clinically localized prostate carcinoma. J Urol. 152:1994;1157-1162.
29. Visakorpi T, Kallioniemi AH, Syvanen AC, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi OP Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res. 55:1995;342-347.
30. Schröder FH, Hermanek P, Denis L, Fair WR, Gospodarowicz MK, Pavone-Macaluso M The TNM classification of prostate cancer. Prostate. 4(Suppl):1992;129-138.